![]() |
OPK Biotech websites
|
![]() |
|
|
IschemiaIschemia - a decrease or lack of red blood cell flow to an organ or area of the body due to obstructed or constricted blood vessels, as in heart attack, stroke and certain medical procedures. The Company's development strategy for ischemia is to assess Hemopure's safety and feasibility in ischemia indications, such as cardiac surgery, wound healing and acute coronary ischemia (e.g. heart attack). In contrast to previous uses where Hemopure was administered as a red blood cell replacement, here it would be used as an oxygen-carrying drug. |
is a Resource Guide for individuals interested in the impact of OPK Biotech LLC's Hemoglobin Based Oxygen Carriers (HBOCs) on laboratory assays. The information presented for Hemopure® also applies to Oxyglobin®. Learn More |
|
©2011 OPK Biotech LLC Legal Statement Terms of Use Privacy Policy Sitemap Home Contact Webmaster |
||